Clinical Journal of the American Society of Nephrology

Article	Citations
Cardiopulmonary Exercise Testing across Interdialytic Intervals in Hemodialysis Patients	419
From Frailty to Fitness	321
Hormones and Nephrons	140
How Will Pregnancy Affect My Kidneys? Moving Closer to Answering This Question for Our Patients	127
Incidence and Risk Factors for Dialysis Reinitiation among Patients with a History of Dialysis Dependency	110
Table of Contents	109
Life's Essential 8, Cardiovascular Health, and CKD Progression among Hispanic/Latino Adults: The Hispanic Community Health Study/Study of Latinos Study	92
Forum of ESRD Networks	78
Characteristics of Populations Included in Randomized Controlled Trials of Hemodiafiltration and Registry Real-Life Populations	77
Boosting CONFIDENCE in Combination Therapy for Diabetic Kidney Disease in Asia	75
How I Treat Challenging Cases of Antibody-Mediated Glomerular Diseases	70
Clonal Hematopoiesis and Cardiovascular Events in Patients with ESKD on Hemodialysis	68
Smart Learning	67
Bisphosphonate Use after Kidney Transplantation Is Associated with Lower Fracture Risk	66
The Role of MicroRNA Regulation on Clinical Outcomes in Kidney Disease	65
A Gut-Wrenching Infection	64
Interpreting the CFH-CFHR Signal in IgA Nephropathy	58
Employment Status and Work Functioning among Kidney Transplant Recipients	57
Glomerular Filtration Markers	57
Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian Adults	55
Surrogate End Points in Apolipoprotein L1–Associated Kidney Disease	54
Dietary Phosphorus and Metabolic Health in CKD and ESKD	54
Application of Natural Language Processing in Nephrology Research	52
Kidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Individuals	51
The Significance of Hematuria in Podocytopathies	51

Pulmonary Hypertension, Right Ventricular Remodeling and Outcomes in Chronic Kidney Disease	49
Effectiveness of Multicomponent Interventions in Slowing Progression of CKD Stages G3-G4	49
Blocking Aldosterone Synthesis	48
Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease	48
Effect of Music in Reducing Pain during Hemodialysis Access Cannulation	46
Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis	45
Implications of Accumulated Cold Time for US Kidney Transplantation Offer Acceptance	44
Plant-Based Diets across the Spectrum of Kidney Disease	43
How the COVID-19 Pandemic Hit Home in North America	43
Care of the Hospitalized Patients with Kidney Failure during COVID-19 Pandemic: Lessons Learned	40
Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19	39
A Patient Whose Family Has Experienced Autosomal Dominant Polycystic Kidney Disease for over Four Generations Shares Their Perspective	38
Preventable Hospitalizations and Kidney Care	38
Genome-Wide Association Study for eGFR in a Taiwanese Population	37
Associations between Different Antivirals and Hospital-Acquired Acute Kidney Injury in Adults with Herpes Zoster	37
Personalized Exercise Prescription for Hemodialysis Patients	36
Perspectives on Drug Development in Early ADPKD	36
Media Analysis of the Canadian Deemed Consent Policy	36
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus Nephritis	35
Table of Contents	35
When Is Genetic Testing Needed in Glomerular Diseases?	34
Neighborhood Socioeconomic Deprivation is Associated with Worse Outcomes in Pediatric Kidney Transplant Recipients	34
Gabapentin, Concomitant Prescription of Opioids, and Benzodiazepines among Kidney Transplant Recipients	34
Cancer Screening among Patients with Kidney Failure Requiring Hemodialysis	34
Table of Contents	33
A New Hope for Treating Podocytopathies	33
Race, Ethnicity, Sex, Gender, Socioeconomic Status, and Representativeness of Race and Ethnicity in ANCA Vasculitis Randomized Trials	32
From Home to Wearable Hemodialysis	32
Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter	32
Prolonged Intermittent Kidney Replacement Therapy	31
Medication Burden and Regimen Complexity Among Dialysis Patients from 2003 to 2024	31
Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study	30
Intradialytic Renal Rehabilitation and Mortality	30
The Predicting Risk of Cardiovascular Disease Event Equation Meets CKD	30
Management of Osteoporosis and Low Bone Mass in Kidney Disease	30
What the Scale Does Not Show	29
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis	29
Comparative Safety of Antidepressants in Adults with CKD	29
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease	28
Stakeholder Theory and For-Profit Dialysis: A Call for Greater Accountability	28
Veterans Health Administration Peritoneal Dialysis Program Infrastructure and Clinical Practices	28
Trends in the Global Burden of Glomerulonephritis	28
Sex and Gender in Science, Medicine, and Nephrology	28
Transforming Dialysis Access Together Dialysis Access Training	28
Racial and Ethnic Disparities in Excess Deaths after COVID-19 Vaccine Deployment among Persons with Kidney Failure	28
The Vexing Problem of Persistent Disparities in Kidney Transplant Care	27
Table of Contents	27
Novel Approaches for the Removal of Uremic Solutes	27
COVID-19 Vaccination in Patients Receiving Dialysis	26
Target Trial Framework	26

Cover Image	26
Predicting Outcomes after Discharge from the Hospital on Dialysis	25
Association of Myosteatosis and of Graft Loss after Kidney Transplantation	25
System-Based Solutions to Minimizing Nephrotoxin-Induced Acute Kidney Injury	24
Exploring the Challenges and Limitations in Participation of Women Nephrologists in Conferences	24
Correction: CRRT Fluid Choices: A Solution for a Common Problem?	24
Safety of Alkalinization in CKD	24
Optimizing Hypertension Control in CKD Through Collaborative Pharmacist Interventions	24
Evaluation and Measurement Properties of a Patient-Reported Experience Measure for Home Dialysis	23
Optimizing Dialysis Vascular Access	23
Cover Image	23
CJASN: A Prelude to the Future	23
Workforce Detachment in Persons with CKD	23
Did the SCORED Trial Get Extra Points for Kidney Outcomes? If So, It Is Not Obvious	23
The Association of Intra-Abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications	22
Baseline, Early Changes, and Residual Albuminuria	22
Cystatin C–Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals	22
IgG4-Related Kidney Disease	22
Favorable Living Donor Kidney Transplantation Outcomes within a National Kidney Exchange Program	22
Exploring Unconscious Bias at International Kidney Conference	22
Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated Vasculitis	21
Hematuria in Podocytopathies	21
Proteinuria Trajectories	21
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings	21
The Role of Water in Uromodulin Regulation	21
Risk of Surgical Site Infections after Tooth Extraction in CKD	21
Management of Pregnancy in Persons with Kidney Failure Treated with Hemodialysis	21
Cover Image	21
Table of Contents	20
Correction: Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis	20
Addressing the Threat to Kidney Health from Modern Diets	20
Table of Contents	20
Signals within Complexity	20
Predictive Models for Kidney Recovery and Death in Patients Continuing Dialysis as Outpatients after Starting in Hospital	20
Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD	20
Abnormal Cardiovascular Functional Responses after the Long Interdialytic Interval	20
More Than a Measure	19
Dialysis for Decades, Then My Heart Breaks	19
Pathogenic Gene Spectrum and Clinical Implication in Chinese Patients with Lupus Nephritis	19
Peritoneal Dialysis Modality Choice	19
Pregnancy in Patients Receiving Home Dialysis	19
Exercise-Associated Hyponatremia in the Grand Canyon	19
HRSA Pushes OPTN Reforms as Criticism of US Organ Transplantation System Increases	19
When “Low-Grade” Is No Longer Low Risk in IgA Nephropathy	18
Drug-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Hemodialysis Fistulae	18
Nutrition across the Entire Lifespan in CKD	18
Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease	18
Resistant Hypertension in Chronic Kidney Disease	18
Early-Start Versus Late-Start Icodextrin for Children Receiving Chronic Peritoneal Dialysis	18
Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network	18
Is Assisted Home Dialysis Feasible in the United States? Addressing Legislative and Regulatory Levers	18
Sequential Biomarker Testing in Kidney Transplant Surveillance	18
How I Treat Nocturnal Home Hemodialysis—An Underprescribed but Essential Home Dialysis Modality in the United States	18
Dissemination and Early Experiences of an Electronic Patient-Reported Outcome Measure in Nephrology Clinic	18
Is the Current Practice of Out-of-Sequence Kidney Allocation Justified? Assessing Outcomes, Utility, Efficiency, and Equity	18
Patterns in Tacrolimus Variability and Association with De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplant Recipients	18
Cell Therapy	18
From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder	18
Kinetics of β-2-Microglobulin with Hemodiafiltration and High-Flux Hemodialysis	17
Setting Up Home Dialysis Programs	17
Hemoadsorption	17
Dialysis Organization Perspectives on the Financial Repercussions of the Expansion of Medicare Advantage	17
SGLT2 Inhibition and Kidney Potassium Homeostasis	17
Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function	17
The Burden of Home Dialysis	17
Digenic Alport Syndrome	17
Mitigating Pain in People Undergoing Hemodialysis	16
Table of Contents	16
Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics	16
Existing Transplant Nephrology Compensation Models and Opportunities for Equitable Pay	16
Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus	16
Just Do It- Exercise before or during Hemodialysis	16
Gait and Balance in People Undergoing Long-Term Hemodialysis	15
Homeward Bound? PD Expansion and Equity in the United States	15
Cover Image	15
Factors Associated with Intradialytic Phosphate Removal in Hemodialysis Patients before and after Parathyroidectomy	15
Table of Contents	15
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality	15
Longitudinal Plasma Metabolome Patterns and Relation to Kidney Function and Proteinuria in Pediatric CKD	15
Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Disease	15

A Survey Study To Assess the Diversity and Inclusion in Nephrology Journal Editorial Leadership	15
Differences in Physical Activity Assessed by Accelerometry across Hemodialysis Days and Shifts	15
Understanding the Determinants of Decision Readiness in Kidney Replacement Therapy	14
Inclement Weather and Risk of Missing Scheduled Hemodialysis Appointments among Patients with Kidney Failure	14
Targeting APRIL in the Treatment of IgA Nephropathy	14
Magnesium Homeostasis	14
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers	14
Derivation and Validation of a Machine Learning Model for the Prevention of Unplanned Dialysis	14
Effects of Semaglutide on Body Composition and GFR	14
Vascular Access Considerations in Home Hemodialysis	14
HIF-PHIs for Anemia Management in CKD	14
Looking into the Future—Preserving Cognitive Function as a Priority in KRT	14
The Role of Online Hemodiafiltration in Contemporary Kidney Care	14
Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial	14
Kidney Denervation	14
Acid-Base Disorders in the Critically Ill Patient	14
Alleviation of Anemia by SGLT2 Inhibitors in Patients with CKD	14
Gender Disparities in Access to Kidney Transplantation	14
The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and Gender Diverse Veterans	14
Management of Intermittent Hemodialysis in the Critically Ill Patient	13
Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones	13
Symptom Trajectories in the Electronic Health Record during the Transition to Maintenance Dialysis	13
International Society for Peritoneal Dialysis Journal Club	13
Large Discordance between Creatinine-Based and Cystatin C–Based eGFRs is Associated with Falls, Hospitalizations, and Death in Older Adults	13
Getting a Kidney: Where Is Patient Choice?	13
To Cool the Dialysate or Not? Question Answered?	13
The Road to APOL1 Genetic Testing in Transplantation	13
Peritoneal Dialysis Outcomes in Autosomal Dominant Polycystic Kidney Disease	13
Why Am I on Dialysis? Gaps in Rural CKD Care in Central California	13
Gender Differences in Citation Rate	13
Kidney Tubule Secretion Can Discriminate the Cause of Acute Kidney Injury in Cirrhosis	13
A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes	13
How We Plan Preconception in Systemic Lupus Erythematosus and Manage Lupus Nephritis in Pregnancy	13
A Scientific Approach to the Use of Racial and Ethnic Identities in Medicine and Kidney Health	13
Exploring the Role of Antithrombin in Nephrotic Syndrome–Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis	13
Sleep Disorders and Dementia Risk in Older Patients with Kidney Failure	13
Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in Chronic Kidney Disease	12
Registered Dietitian Nutritionists and Medical Nutrition Therapy	12
Cover Image	12
Thresholds of Kidney Function Decline and Congestion Status and Their Relation with Outcomes among Discharged Heart Failure Patients	12
How I Treat IgA Nephropathy	12
Fructokinase Inhibition to Prevent Kidney Disease	12
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems	12
Polycystic Kidney Disease Diet	12
Should We Really Still Be Using Creatinine in the Critical Care Setting?	12
Central Venous Catheter Malfunction in Children	12
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones	12
Palliative Care for Hemodialysis Patients?	12
Developing Therapies for C3 Glomerulopathy	12
Nephrotoxin Exposure and Acute Kidney Injury in Adults	12
Physician Preferences for Lower-Quality Kidney Offers	12
Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Mortality in Patients with ESKD	12
Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD	12
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients	11
Nature and Nurture? The Case of Polycystic Kidney Disease	11
Central Body Fat Distribution and Kidney Function after Living Kidney Donation	11
Hypothermic Perfusion Mitigates Extended Cold Ischemia Time in Kidney Transplantation	11
Table of Contents	11
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Primary Aldosteronism	11
Antivirals in Herpes Zoster and AKI	11
Reducing the Risks of Home Dialysis Innovation and Uptake	11
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with and without Advanced CKD	11
Association between Area Deprivation Index, Kidney Transplant Waitlisting, and Reasons for Denial	11
Climate and the Nephrologist	11
Innovating Kidney Care in Patients with Cancer	11
Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial	11
Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype	11
The Unfulfilled Promise of Belding Scribner	11
Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting	11
Cover Image	11
Rare Kidney Diseases	11
Perspectives and Experiences of Patients with AKI	11
Considering the Treatment of IgA Nephropathy	11
Impact of a Longitudinal Virtual Education Series on Home Dialysis Education	10
Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy	10
Dialysate Sodium Lowering in Maintenance Hemodialysis	10
Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2–Infected versus Noninfected Deceased Donors	10
Use of Aspirin and Initial Cardiovascular and Bleeding Risk in Patients with Chronic Kidney Disease	10
Radiographic Contrast Media and the Kidney	10
Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis	10
Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and CKD	10
Managing Patients with Hyperchloremia	10
Shared Family Experiences with Kidney Disease	10
Implementation and Effectiveness of a Learning Collaborative to Improve Palliative Care for Seriously Ill Hemodialysis Patients	10
Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney Disease	10
Mechanisms of Antihypertensive Effect of Chlorthalidone in Advanced Chronic Kidney Disease	10
Pathophysiology of Arteriovenous Fistula Maturation and Nonmaturation	10
Kidney Volume as a Predictor and Modifier of Acute Kidney Injury with Renin-Angiotensin System Inhibitors	10
Fracture in Association with Anticoagulant Therapy in Patients with CKD and Atrial Fibrillation	10
Effect of Carbamylation and Anemia on the Association between Glycated Albumin and Kidney Outcomes in Diabetic Kidney Disease	10
Effect of Spironolactone on Kidney Function in Kidney Transplant Recipients (the SPIREN trial)	10
Decision Readiness and Determinants of KRT among Veterans with Advanced CKD	10
Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes	10
The National Organ Transplant Act Must Be Updated to Meet the Demands of Transplantation's Future	10
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1	10